Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by ProfCorneliuson Apr 11, 2020 2:25pm

302 Views

Post# 30899196

RE:RE:RE:131.77M and 163.12M CDN

ZipLokBaggies4U wrote: Reliable sources told me 160m+

GrandSabot wrote:

ProfCornelius wrote: Why are these numbers important to us? Because as far as the street is concerned those two numbers are consensus targets that Aphria needs to not only hit but beat. The first is for Q3 2020 and the second is for Q4 2020. We beat these and we will be considered #1! Especially with how tidy our balance sheet looks. TRST will be booted off the NYSE soon and ACB and HEXO are struggling just to stay on. I'm not sure if they will manage to stay on but if you're a Canadian LP playing the long game you need to be listed on a US big board especially for when cannabis gets legalized in the US. Aphria is set up quite nicely to do just that. We will be #1. #1 in capacity. Check #1 in production. Check #1 in sales revenue. By year's end. #1 in EBITDA. Check Look for 6.4M CDN this Q. #1 in EPS. Check #1 in Europe. After COVID19 Prof

My intel tells me we'll be north of 140. TGS

Zippy4U,

LOL, very clever name...like

I think I know who you are and who your sources are...all good bro!

If we hit 160M plus I am pretty sure that both TGS and I will be happy to be wrong...

Prof

#154MQ3